Next |
home / stock / prog / prog message board
Subject | By | Source | When |
---|---|---|---|
Is Biora Therapeutics (PROG) Stock About to Go Big? | AstronautApe_888 | investorshub | 01/12/2023 4:52:18 AM |
What happened here...it looks like trading has halted | pinkslipjunkie | investorshub | 06/17/2022 8:52:24 PM |
Hi, what to expect on the 28th ? | Hobbydigger-53 | investorshub | 03/26/2022 8:48:32 PM |
You got that right! | nathanial | investorshub | 03/19/2022 9:16:19 PM |
The pumpers got ahead of it last time | Deano361 | investorshub | 03/18/2022 3:14:10 PM |
About bloody time!!!! | Limey42 | investorshub | 03/18/2022 2:33:46 PM |
Gametime!! | Deano361 | investorshub | 03/18/2022 2:24:51 PM |
This turned into something different than expected. Athyrium | Deano361 | investorshub | 03/14/2022 1:35:19 PM |
$1.23 is on the ask. | MASTERULTRA | investorshub | 03/14/2022 8:05:14 AM |
Please god,let us close $1.30 | MASTERULTRA | investorshub | 03/11/2022 6:29:21 PM |
Holyshit, its a miracle thank you jesus!!! | MASTERULTRA | investorshub | 03/11/2022 5:56:04 PM |
#$PROG ?? Nice uptrend! Are you in or | da_stock_analyst | investorshub | 02/10/2022 3:41:16 AM |
Yes | Deano361 | investorshub | 01/31/2022 5:08:36 PM |
#$PROG ?? is it reversing? Good to re-enter | da_stock_analyst | investorshub | 01/30/2022 11:20:42 PM |
Options chain getting nice and full for next | plumber652 | investorshub | 01/15/2022 2:55:59 AM |
Much dilution, debt reduction off of the backs | tooltimetim | investorshub | 01/14/2022 2:04:50 AM |
added premarket. Jan' effect needs to kick in! | dmerc | investorshub | 01/13/2022 1:35:22 PM |
Every dog gets it's day and we will | Deano361 | investorshub | 01/12/2022 4:45:05 PM |
Phew, I almost missed the boat lol | Torez | investorshub | 01/11/2022 11:46:59 PM |
$PROG IS GOING UP TODAY. BABY. GLTA $PROG APES | Stockman1010101 | investorshub | 01/11/2022 2:42:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Progenity Inc. Company Name:
PROG Stock Symbol:
NASDAQ Market:
All performance targets achieved in single-ascending dose (SAD) cohorts of BT-600 clinical trial Results demonstrated targeted drug delivery and absorption in the colon, with 3-4 times lower drug levels in blood Remainder of BT-600 clinical trial progressing well and on schedule...
SAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it will report financial results and provide a corporate update for the fourth quarter and full year ended December 31, 2023. T...
Monetization of legacy asset brings in $3 million in nondilutive capital Convertible notes exchange brings in another $2.8 million in new capital and reduces Biora’s net debt SAN DIEGO, March 11, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech ...